Immunotherapy of Malignant Glioma by Noninvasive Administration of TLR9 Agonist CpG Nano-Immunoadjuvant.
Adv Sci (Weinh)
; 9(13): e2103689, 2022 05.
Article
in En
| MEDLINE
| ID: mdl-35253404
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Toll-Like Receptor 9
/
Glioma
Limits:
Animals
Language:
En
Journal:
Adv Sci (Weinh)
Year:
2022
Document type:
Article
Country of publication: